Explore By Subject Area   

Lead Editorial

How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign

How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign

Holly John, Senior Director of Global Patient Advocacy and Medical Affairs at Agios Pharmaceuticals, shares insights from the company’s partnership with the sickle cell community on the RISE UP Phase 2/3 trial of mitapivat in sickle cell disease

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.